Clinical Trials Directory

Trials / Unknown

UnknownNCT02029534

Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF)

Intensive Statin Therapy Effect on Incidence of Post-Operative Atrial Fibrillation

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Creighton University · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

This study will compare the effects of 20 mg of atorvastatin to 80 mg of atorvastatin for the prevention of atrial fibrillation after cardiothoracic surgery. The study hypothesis is that 80 mg of atorvastatin will be more effective at preventing atrial fibrillation compared to 20 mg.

Detailed description

This is a randomized, double-blind comparison of two doses of atorvastatin for prevention of post-operative atrial fibrillation.

Conditions

Interventions

TypeNameDescription
DRUGAtorvastatin 20 mg
DRUGAtorvastatin 80 mg

Timeline

Start date
2013-08-01
Primary completion
2017-06-01
Completion
2017-06-01
First posted
2014-01-08
Last updated
2016-06-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02029534. Inclusion in this directory is not an endorsement.

Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF) (NCT02029534) · Clinical Trials Directory